Braingaze develops next-generation Mind Tracking Solutions that predict and identify personal behavior for clinical and commercial applications.

The method of Braingaze (patented in 44 countries) is based on the discovery of the predictive power of small eye movements as a marker for cognitive visual processing. We call this eye movement Cognitive Vergence. Braingaze method is non-invasive, fast and can be integrated into existing eye tracking devices and software.

In most applications we engage with the test subject by means of a simple video game; the Cognitive Vergence eye movements are captured in sync with the game timing to allow us to draw very meaningful conclusions within minutes of testing.

As a first clinical application Braingaze has validated its test for diagnosing ADHD in children. In this area our technology is showing superior precision & reliability compared to any other competing ADHD test available on the market. This product was launched in a few pioneer mar...
Braingaze develops next-generation Mind Tracking Solutions that predict and identify personal behavior for clinical and commercial applications.

The method of Braingaze (patented in 44 countries) is based on the discovery of the predictive power of small eye movements as a marker for cognitive visual processing. We call this eye movement Cognitive Vergence. Braingaze method is non-invasive, fast and can be integrated into existing eye tracking devices and software.

In most applications we engage with the test subject by means of a simple video game; the Cognitive Vergence eye movements are captured in sync with the game timing to allow us to draw very meaningful conclusions within minutes of testing.

As a first clinical application Braingaze has validated its test for diagnosing ADHD in children. In this area our technology is showing superior precision & reliability compared to any other competing ADHD test available on the market. This product was launched in a few pioneer markets in Europe in 2016.

In parallel to the behavioral disorder diagnosis market (ADHD as a first product but also in our product pipeline are autism, dislexia, Alzheimer) we are collaborating with major FMCG firms like Procter & Gamble on application of our technology in Consumer Insight research. Commercial products in this area are planned for later in 2016 once validation has been completed.

A third area where we are developing applications of our technology is that of cognitive development tracking in infants and children. In the framework of an exploratory grant from the Bill & Melinda Gates Foundation we have successfully captured very meaningful data in infants as young as 9 months of age. We are presently planning a next phase in this research which will allow us to have normative data that can be used to measure and benchmark cognitive development in a range of key cognition areas in children in a one hour gameplay test. Presently such testing is not possible at this young age; for children at later ages it is possible but requires several days of testing by a trained psychiatrist.
More information

Investors

Startup-Scaleup
Admin
Startup-Scaleup Startup Europe's IOT Accelerator